Korea Comirnaty Post-marketing Surveillance

Clinical trial NCT05032976 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05032976
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

COVID-19 Vaccines Adverse Effects SARS-CoV-2 Safety

Start date: 2022-03-18
Primary completion: 2027-01-24
Enrollment: 12000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.